கருப்பை புற்றுநோய்
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
எங்கே போக வேண்டும்
இந்த trial-க்காக இந்தியால 1 hospital நோயாளிகளை சேர்க்குறாங்க.
ரெஜிஸ்ட்ரி சுருக்கம் (டெக்னிக்கல்)
Peritoneal carcinomatosis is a common event in the natural history of colorectal and other digestive tract cancers. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provides a promising therapeutic option for highly selected patients with peritoneal carcinomatosis arising from different malignancies such as colorectal cancer, gastric cancer, ovarian cancer, or peritoneal mesothelioma with improvement of both patient survival and quality of life. CRS, i.e., removal of all visible metastatic abdominal and pelvic disease with peritonectomy along with HIPEC (for 90…
ஸ்பான்சர்: Tata Memorial Centre
NCT02754115 on ClinicalTrials.gov
Last updated on the registry 21 Nov 2024 · read by us 20 Oct 2026